Study guide
8.2 Coagulopathies, Myelosuppression & Oncologic Complications
AACN CCRN Pediatric Critical Care Certification Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Fees & Renewal 1.3 Test Plan & Study Strategy
2 Cardiovascular I — Structure & Procedures
2.1 Cardiac Malformations 2.2 Cardiac Surgery & Catheterization 2.3 Cardiac Transplant
3 Cardiovascular II — Hemodynamics
3.1 Cardiogenic Shock 3.2 Heart Failure & Cardiomyopathies 3.3 Inflammatory Disease, Hypertensive Crisis & Vascular Occlusions
4 Cardiovascular III — Rhythm
4.1 Pediatric Dysrhythmias 4.2 Conduction System Defects
5 Respiratory I — Acute Failure
5.1 ARDS & Acute Respiratory Failure 5.2 Pulmonary Embolus & Acute Respiratory Infection 5.3 Chronic Respiratory Failure & Pulmonary Conditions
6 Respiratory II — Specialty Airway
6.1 Airway Malformations & Status Asthmaticus 6.2 Pulmonary Hypertension 6.3 Thoracic & Airway Trauma and Thoracic Surgery
7 Endocrine Emergencies
7.1 Diabetes Mellitus & DKA 7.2 Hyperglycemia & Hypoglycemia 7.3 DI, SIADH & Cerebral Salt Wasting
8 Hematology & Immunology
8.1 Sickle Cell Crisis 8.2 Coagulopathies, Myelosuppression & Oncologic Complications 8.3 Transfusion Reactions, Immune Deficiencies, Anemia & BMT
9 Gastrointestinal
9.1 Congenital GI Abnormalities & NEC 9.2 GI Hemorrhage, Abdominal Trauma & Peritonitis 9.3 Hepatic Failure, Malnutrition & GI Surgery
10 Renal/GU & Integumentary
10.1 AKI, CKD & Life-Threatening Electrolytes 10.2 HUS & Kidney Transplant 10.3 Integumentary Injuries
11 Neurological I — Acute Brain Injury
11.1 Traumatic Brain Injury & Intracranial Hemorrhage 11.2 Seizure Disorders, Encephalopathy & Delirium 11.3 Hydrocephalus & Congenital Neurological Abnormalities
12 Neurological II, Musculoskeletal & Behavioral
12.1 Neuro Infection, Neuromuscular Disorders & Neurosurgery 12.2 Stroke, Brain Death & Space-Occupying Lesions 12.3 Musculoskeletal Critical Care 12.4 Behavioral & Psychosocial Care
13 Multisystem I — Shock & Inflammation
13.1 Sepsis & SIRS 13.2 Shock States & MODS 13.3 Acid-Base, Pain & Healthcare-Acquired Conditions
14 Multisystem II — Crisis & Goals of Care
14.1 Burns & Thermal Injury 14.2 Submersion Injury 14.3 Toxic Ingestion, Inhalation & Exposure 14.4 End-of-Life, Palliative Care & Organ Donation
15 Professional Caring I — Synergy, Advocacy & Caring
15.1 AACN Synergy Model Overview 15.2 Advocacy & Moral Agency 15.3 Caring Practices & Clinical Inquiry
16 Professional Caring II — Collaboration, Diversity & Systems
16.1 Collaboration, Facilitation of Learning & Response to Diversity 16.2 Systems Thinking
8.2 Coagulopathies, Myelosuppression & Oncologic Complications
Key Takeaways Explain This Topic AI
Pediatric ITP is usually isolated thrombocytopenia with mucocutaneous bleeding; PICU concern rises with intracranial hemorrhage risk, wet purpura, or hemodynamic compromise from bleeding.
DIC in critically ill children is consumptive — low platelets, low fibrinogen, prolonged PT/aPTT, high D-dimer — and management starts by treating sepsis, trauma, or other triggers plus product support for active bleeding.
HIT is an immune prothrombotic reaction after heparin exposure; stop all heparin and start a non-heparin anticoagulant when clinical probability is high, even before assay return.
Tumor lysis syndrome produces hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia; PICU priorities are telemetry, aggressive hydration, uric-acid control, and readiness for dialysis.
Fever with neutropenia is an oncologic emergency: obtain cultures and give broad anti-pseudomonal antibiotics within the first hour while searching for a source.
Last updated: July 2026
Coagulopathy Landscape in the PICU
Critically ill children develop bleeding and clotting disorders from immune platelet destruction, consumptive cascades, drug reactions, marrow failure, and cancer therapy. The CCRN Pediatric exam expects you to separate immune thrombocytopenia (ITP) , disseminated intravascular coagulation (DIC) , and heparin-induced thrombocytopenia (HIT) , then layer myelosuppression complications — especially tumor lysis syndrome (TLS) and febrile neutropenia .
Immune Thrombocytopenia (ITP)
Immune thrombocytopenia (ITP) is antibody-mediated platelet destruction, often following a viral illness in previously healthy children. Platelet counts may fall below 20,000/uL while hemoglobin and leukocyte counts remain normal. Clinical picture is mucocutaneous : petechiae, purpura, epistaxis, gingival bleeding, and menorrhagia in adolescents. Deep tissue or joint bleeding is less typical than in hemophilia.
Most childhood ITP is self-limited, but PICU-level concern focuses on life-threatening hemorrhage , particularly intracranial hemorrhage (ICH) — heralded by severe headache, vomiting, neurologic change, or “wet purpura” (bullous oral hemorrhage). Management may include IVIG, corticosteroids, or other immunomodulation per hematology; platelet transfusion is reserved for life-threatening bleed because transfused platelets are rapidly destroyed unless the acute emergency demands them. Nursing priorities: neuro checks, fall precautions, avoid IM injections and rectal temperatures, soft toothbrush, and rapid escalation for neurologic red flags.
Disseminated Intravascular Coagulation (DIC)
DIC is a consumptive coagulopathy triggered by sepsis (especially meningococcemia and gram-negative infection), trauma, burns, malignancy, and severe hemolytic reactions. Systemic thrombin generation creates microthrombi that injure organs while platelets and clotting factors are consumed , so the child both clots and bleeds. Bedside clues include oozing from lines and mucosa, purpura fulminans, oliguria, and acral ischemia.
- Parameter Typical DIC pattern Clinical meaning
- Platelets Falling / low Consumed in microthrombi
- Fibrinogen Low Consumed into fibrin
- PT / aPTT Prolonged Factor depletion
- D-dimer / FDPs Markedly high Fibrinolysis of clots
- Smear Schistocytes may appear Microangiopathic shear
Treat the cause first — antibiotics and source control for septic DIC remain the decisive step. Product support targets active bleeding plus labs : FFP for prolonged PT/aPTT, cryoprecipitate for critically low fibrinogen, and platelets for severe thrombocytopenia with bleeding. Heparin is rarely first-line in bleeding-predominant pediatric DIC and is considered only in selected thrombosis-predominant pictures under specialist guidance.
Heparin-Induced Thrombocytopenia (HIT)
Although less common than in adults, HIT occurs in heparin-exposed children (including line flushes and ECMO circuits). IgG against heparin–PF4 complexes activates platelets, producing a prothrombotic state despite thrombocytopenia. Suspect HIT with a >50% platelet drop typically on days 5–10 of exposure (sooner if prior heparin), new thrombosis, and no clearer alternate cause. Actions that cannot wait for serology: stop all heparin (unfractionated, LMWH, and heparin-coated devices when feasible) and start a non-heparin anticoagulant (e.g., argatroban or another agent chosen for age, organ function, and institutional protocol). Avoid prophylactic platelet transfusion and early warfarin, which can worsen limb ischemia.
Myelosuppression and Oncologic Complications
Chemotherapy and hematologic malignancies suppress marrow lineages: anemia, thrombocytopenia, and neutropenia . Absolute neutrophil count ( ANC ) <500/uL (and especially <100/uL) marks profound infection risk because neutrophils are the primary defense against bacterial and fungal invasion.
Tumor Lysis Syndrome (TLS)
Tumor lysis syndrome follows rapid malignant-cell breakdown — spontaneously in bulky high-grade lymphomas/leukemias or shortly after induction therapy. Intracellular contents flood the plasma:
- Hyperkalemia → arrhythmias, peaked T waves, widened QRS
- Hyperphosphatemia → binds calcium
- Secondary hypocalcemia → tetany, seizures, prolonged QT
- Hyperuricemia → precipitation in renal tubules → acute kidney injury
PICU TLS bundle: continuous cardiac monitoring; vigorous IV hydration (often 2–3 L/m²/day when cardiac/renal status allows); urinary alkalinization only when specifically ordered and not if phosphate is already high; urate oxidase (rasburicase) or allopurinol per risk strata and G6PD status (rasburicase contraindicated in G6PD deficiency); frequent labs (q4–6h initially); kayexalate/insulin-glucose/calcium for dangerous potassium; and early nephrology for oliguric AKI or refractory electrolyte crises requiring dialysis. Never add potassium to fluids in active TLS.
Neutropenic Fever
Fever in neutropenia is an emergency because an unopposed bacterial infection can progress to septic shock within hours. Definitions commonly use a single oral temperature ≥38.3°C (101°F) or ≥38.0°C (100.4°F) sustained over one hour with ANC <500/uL (or expected to fall there). Immediate actions:
Rapid assessment for shock and focus of infection (lines, mucosa, perineum, lungs, abdomen).
Blood cultures from periphery and each lumen before antibiotics when obtainable without delay.
Broad-spectrum anti-pseudomonal antibiotics within 60 minutes (and preferably sooner).
Strict protective practices: hand hygiene, private room as indicated, avoid rectal manipulation, meticulous central-line care, and early consideration of antifungal coverage for persistent fever per oncology protocols.
- Scenario First PICU priority Pitfall to avoid
- ITP with headache/vomiting Neuro imaging / ICH pathway Assuming “just low platelets”
Septic child with oozing + low fibrinogen Treat sepsis + products for bleed Transfusing to numbers without source control
- Day-6 heparin, platelets halved, new clot Stop heparin + non-heparin AC Platelet transfusion as sole therapy
- New chemo, K⁺ 6.2, uric acid rising TLS protocol + telemetry Potassium-containing maintenance fluids
- ANC 200, T 38.5°C Cultures + anti-pseudomonal Abx <1 h Waiting for “culture results first”
Integrate family teaching: fever instructions at discharge, central-line emergency signs, and medication adherence for growth-factor or antimicrobial prophylaxis when prescribed. The exam rewards recognizing that time-to-antibiotic in febrile neutropenia and time-to-metabolic control in TLS are as critical as ventilator or vasoactive titration elsewhere in the PICU.